From data to dossier

From study data to complete,
validated dossier.

Metamorphic AI is built for pharmaceutical and biotech organisations that need to move faster, operate more efficiently, and deliver without compromising regulatory quality.

Request a Briefing
✦ISO 27001 Certified ✦SOC 2 Type II ✦Full eCTD Document Suite ✦FDA · EMA · PMDA ✦Complete Audit Trail ✦Validated with Biotech Partners ✦ISO 27001 Certified ✦SOC 2 Type II ✦Full eCTD Document Suite ✦FDA · EMA · PMDA ✦Complete Audit Trail ✦Validated with Biotech Partners
The Problem

Decades of investment.
The bottleneck hasn't moved.

Then
Months of effort.
Teams of writers.
The starting point for clinical evidence production.
Now
Months of effort.
Teams of writers.
Technology was added to the edges of an unchanged process. The bottleneck was never the tools — it was the workflow itself.

The manual authoring workflow has never had a natural efficiency ceiling. The more complex the pipeline, the more resource it consumes. Quality is inconsistent and hard to govern at scale.

And the process optimises for completeness over clarity — adding to the regulatory review burden rather than reducing it.

These are not performance gaps. They are structural features of the workflow itself.

Resource
The more complex the pipeline, the more headcount it requires. There is no natural efficiency gain in the traditional model.
Quality
Inconsistent outputs, governed by individual expertise. Hard to standardise. Harder to scale.
Regulatory burden
A process that optimises for completeness over clarity adds to the review burden rather than reducing it.

The natural response was software and AI.

Software. Writing assistants. Quality checkers. Data extractors. Each deployed to address a specific bottleneck. Each produced initial gains.

Value vs. AI Investment — Siloed point solutions vs. Orchestrated platform
VALUE AI INVESTMENT & SCOPE Single document type Scaling attempt Full dossier scope Initial gains Coordination breaks down Cost of chaos Metamorphic AI Scales with the dossier Siloed point solutions Orchestrated platform

When AI is deployed tool by tool, without a layer to coordinate it, the gains compound into a new problem. Each document type gets its own tool, its own vendor, its own validation exercise. None of them share context with the others.

Specialist knowledge built into one tool is invisible to the next. A clinical judgement applied consistently in one document has no way of propagating across the dossier. The review burden that was supposed to shrink instead grows, as human reviewers are left to reconcile what the individual tools cannot.

More investment in siloed AI deepens the problem. It doesn't solve it.

This is
The Agentic Value Trap.
The way out
The Metamorphic AI orchestration engine enables a singular system to carry the same clinical knowledge, regulatory logic, and terminology across every document in the dossier — by design, not by integration.
The Platform

One platform. Every document.
Your standards.

Metamorphic AI covers the full eCTD document suite under a single, governed platform that enforces consistency across every document in your dossier. Configured to your organisation's standards. Certified to ISO 27001 and SOC 2 Type II.

Metamorphic Works

Autonomous authoring from study data to complete, validated report.

  • →
    Complete, validated output Produces a complete, validated document that reflects your organisation's writing standards, regulatory requirements, and established practices.
  • →
    Direct from source data Statistical outputs flow directly into document generation — eliminating the copy-paste handoff that is the primary source of data errors in manual workflows.
  • →
    Near-zero data errors Every figure reconciled against its source data automatically.
  • →
    Consistent across the dossier Every document draws from the same governed knowledge base — the same data, the same terminology, the same regulatory logic. Documents that are supposed to tell the same clinical story do.
Full eCTD coverage
CSR
Clinical Summaries
Overviews
Protocols
Investigator Brochures
Informed Consent
Plain Language Summaries
Meeting Packages
additional document types
Regulatory Overviews
TFLs
ADaM Datasets
Compliance & Security
ISO 27001 certified
SOC 2 Type II certified
Full regulatory audit trail across all documents
Your standards and study data fully isolated
Designed for validated pharmaceutical environments
ISO 27001 Certificate SOC 2 Type II Certificate
The full platform is available to view under briefing. We start with a conversation about your process — then show you precisely how the platform addresses it.
Request a Briefing
The Transformation

Built by people who have
delivered this before.

Metamorphic AI was founded by Louise Lind Skov and Waheed Jowiya, who bring over 25 years of combined experience in pharmaceutical medical writing and regulatory affairs.

Before founding Metamorphic AI, the founders led one of the most significant document automation transformations in the industry at a major global pharmaceutical company — gaining direct experience of what it actually takes to change this process in a regulated enterprise environment. That programme demonstrated that the clinical evidence pipeline could be fundamentally redesigned. Metamorphic AI was founded to deliver that transformation at scale.

Wall Street Journal The Information Fortune
What a real transformation requires

Available technology has reached the limits of what it can deliver within unchanged workflows. A real transformation requires four things working together.

Technology matched to the problem
Identifying the bottleneck before building the solution prevents the common failure mode of deploying tools into an unchanged process and expecting different outcomes.
Process that changes, not just gets augmented
The shift from a linear, sequential workflow to an AI-enabled one requires genuine redesign — not new tools bolted onto an old way of working.
People transitioned deliberately
Role changes announced rather than managed are the single most consistent reason AI deployments fail to deliver sustained value at scale.
Knowledge that compounds over time
The platform improves with every document it processes. Organisations that invest in this from the first deployment extract compounding value.

Role evolution, not role elimination.

Metamorphic AI delivers a structured transition programme — moving teams through defined stages as confidence and output quality build, so the organisation extracts value at every point in the journey.

01
Working alongside
Teams work alongside the platform — reviewing outputs, building institutional familiarity, and contributing the domain knowledge that shapes future generation. Human expertise remains central.
02
Shifting to refinement
As output quality matures and the platform is validated against the organisation's standards, the balance shifts. Effort moves from creation to refinement — a more leveraged application of expertise.
03
Concentrated at the point of judgement
Human involvement concentrates where it belongs — on clinical narrative, regulatory integrity, and decisions that require genuine expertise. Routine tasks have been absorbed by the platform.
04
Strategic oversight
The organisation reaches a new operating model. A small, highly capable team governs the platform and owns the strategic clinical narrative across the portfolio. The expertise is still essential — applied at a level that reflects it.
This is not role elimination. It is role evolution — managed deliberately, with defined milestones, so the organisation extracts value at every stage of the transition.
Results

What the transformation
looks like in practice.

From a large-scale transformation programme led by the Metamorphic AI founders, validated with two biotech partners within the first two months of operation. The figures below reflect a single document type — the Clinical Study Report — at an organisation producing between 70 and 100 CSRs per year.

Metric Manual Metamorphic AI
CSR authoring time60–80 days10–30 minutes
Per-reviewer review timeDays to weeks20–40 minutes
Time to final document12–15 weeksSame day as final data
FTEs for CSR production~503
CSRs per writer per year2–3Up to 100
Data errors per CSR~40Near zero
Review comment trendStable / growingDeclining with each CSR
>90%
Reduction in time to final document
12–15 weeks to same day as final data
50→3
FTEs required for CSR production
From a large-scale prior transformation
"Complete but redundant — excessive detail obscuring the important findings and making review somewhat tedious."
Ex-Deputy Division Head, FDA — on traditionally authored CSRs
Get Started

Not a vendor.
We deliver the outcome.

We start with a conversation about your process, your constraints, and your timeline — then show you precisely how the platform addresses them.

Request a Briefing